Elekta's Evo Revolutionizes Cancer Treatment in India

Elekta has launched its groundbreaking CT-based linear accelerator, Evo, in India. This innovative technology enhances imaging capabilities with AI, enabling precise cancer treatment. It's a significant addition to India's healthcare sector, providing adaptable radiation therapy solutions for complex cases and expanding access to quality cancer care.

Elekta, a leader in precision radiation therapy, has officially launched its cutting-edge Evo CT-based linear accelerator in the Indian market. This innovative device offers clinicians enhanced imaging capabilities powered by artificial intelligence, aimed at improving cancer treatment outcomes.

The Evo accelerator, previously introduced in Europe and other markets, was recently showcased at the Association of Radiation Oncologists of India Conference (AROICON) in Kolkata. The Evo provides adaptive radiation therapy capabilities, allowing for the customization of treatment techniques to suit individual patient needs.

Feras Al Hasan, the Head of TIMEA at Elekta, highlighted the importance of Evo's feature in managing complex and advanced-stage diseases commonly seen in India. By offering both online and offline adaptive treatments, Evo empowers clinicians to adjust therapies in response to daily anatomical changes, reinforcing Elekta's commitment to global cancer treatment accessibility.

(With inputs from agencies.)